 | • レポートコード：QYR2104Z1064 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、がん悪液質のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プロゲストゲン、コルチコステロイド、併用療法、その他）、用途別市場規模（病院店、小売薬局店、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がん悪液質の市場動向 ・企業の競争状況、市場シェア ・がん悪液質の種類別市場規模（プロゲストゲン、コルチコステロイド、併用療法、その他） ・がん悪液質の用途別市場規模（病院店、小売薬局店、オンライン薬局） ・がん悪液質の北米市場規模2016-2027（アメリカ、カナダ） ・がん悪液質のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん悪液質のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん悪液質の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん悪液質の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Aeterna Zentaris、Alder BioPharmaceuticals、Aphios、Eli Lilly、GTx、Helsinn、Merck、Novartis、Bristol-Myers Squibb、XBiotech） ・結論 |
Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors.
Market Analysis and Insights: Global Cancer Cachexia Market
The global Cancer Cachexia market size is projected to reach US$ 2130.6 million by 2026, from US$ 1591 million in 2019, at a CAGR of 4.2% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Cachexia market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Cachexia market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Cachexia market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Cachexia market.
Global Cancer Cachexia Scope and Market Size
Cancer Cachexia market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Cachexia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Progestogens
Corticosteroids
Combination Therapies
Others
Segment by Application
Hospital Stores
Retails Pharmacy Store
Online Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Aeterna Zentaris
Alder BioPharmaceuticals
Aphios
Eli Lilly
GTx
Helsinn
Merck
Novartis
Bristol-Myers Squibb
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Cachexia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Progestogens
1.2.3 Corticosteroids
1.2.4 Combination Therapies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cancer Cachexia Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Stores
1.3.3 Retails Pharmacy Store
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Cachexia Market Perspective (2016-2027)
2.2 Cancer Cachexia Growth Trends by Regions
2.2.1 Cancer Cachexia Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Cachexia Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Cachexia Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Cachexia Industry Dynamic
2.3.1 Cancer Cachexia Market Trends
2.3.2 Cancer Cachexia Market Drivers
2.3.3 Cancer Cachexia Market Challenges
2.3.4 Cancer Cachexia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Cachexia Players by Revenue
3.1.1 Global Top Cancer Cachexia Players by Revenue (2016-2021)
3.1.2 Global Cancer Cachexia Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Cachexia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Cachexia Revenue
3.4 Global Cancer Cachexia Market Concentration Ratio
3.4.1 Global Cancer Cachexia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Cachexia Revenue in 2020
3.5 Cancer Cachexia Key Players Head office and Area Served
3.6 Key Players Cancer Cachexia Product Solution and Service
3.7 Date of Enter into Cancer Cachexia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Cachexia Breakdown Data by Type
4.1 Global Cancer Cachexia Historic Market Size by Type (2016-2021)
4.2 Global Cancer Cachexia Forecasted Market Size by Type (2022-2027)
5 Cancer Cachexia Breakdown Data by Application
5.1 Global Cancer Cachexia Historic Market Size by Application (2016-2021)
5.2 Global Cancer Cachexia Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Cachexia Market Size (2016-2027)
6.2 North America Cancer Cachexia Market Size by Type
6.2.1 North America Cancer Cachexia Market Size by Type (2016-2021)
6.2.2 North America Cancer Cachexia Market Size by Type (2022-2027)
6.2.3 North America Cancer Cachexia Market Size by Type (2016-2027)
6.3 North America Cancer Cachexia Market Size by Application
6.3.1 North America Cancer Cachexia Market Size by Application (2016-2021)
6.3.2 North America Cancer Cachexia Market Size by Application (2022-2027)
6.3.3 North America Cancer Cachexia Market Size by Application (2016-2027)
6.4 North America Cancer Cachexia Market Size by Country
6.4.1 North America Cancer Cachexia Market Size by Country (2016-2021)
6.4.2 North America Cancer Cachexia Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cancer Cachexia Market Size (2016-2027)
7.2 Europe Cancer Cachexia Market Size by Type
7.2.1 Europe Cancer Cachexia Market Size by Type (2016-2021)
7.2.2 Europe Cancer Cachexia Market Size by Type (2022-2027)
7.2.3 Europe Cancer Cachexia Market Size by Type (2016-2027)
7.3 Europe Cancer Cachexia Market Size by Application
7.3.1 Europe Cancer Cachexia Market Size by Application (2016-2021)
7.3.2 Europe Cancer Cachexia Market Size by Application (2022-2027)
7.3.3 Europe Cancer Cachexia Market Size by Application (2016-2027)
7.4 Europe Cancer Cachexia Market Size by Country
7.4.1 Europe Cancer Cachexia Market Size by Country (2016-2021)
7.4.2 Europe Cancer Cachexia Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Cachexia Market Size (2016-2027)
8.2 Asia-Pacific Cancer Cachexia Market Size by Type
8.2.1 Asia-Pacific Cancer Cachexia Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Cachexia Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Cachexia Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Cachexia Market Size by Application
8.3.1 Asia-Pacific Cancer Cachexia Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Cachexia Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Cachexia Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Cachexia Market Size by Region
8.4.1 Asia-Pacific Cancer Cachexia Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Cachexia Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Cachexia Market Size (2016-2027)
9.2 Latin America Cancer Cachexia Market Size by Type
9.2.1 Latin America Cancer Cachexia Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Cachexia Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Cachexia Market Size by Type (2016-2027)
9.3 Latin America Cancer Cachexia Market Size by Application
9.3.1 Latin America Cancer Cachexia Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Cachexia Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Cachexia Market Size by Application (2016-2027)
9.4 Latin America Cancer Cachexia Market Size by Country
9.4.1 Latin America Cancer Cachexia Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Cachexia Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Cachexia Market Size (2016-2027)
10.2 Middle East & Africa Cancer Cachexia Market Size by Type
10.2.1 Middle East & Africa Cancer Cachexia Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Cachexia Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Cachexia Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Cachexia Market Size by Application
10.3.1 Middle East & Africa Cancer Cachexia Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Cachexia Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Cachexia Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Cachexia Market Size by Country
10.4.1 Middle East & Africa Cancer Cachexia Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Cachexia Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Aeterna Zentaris
11.1.1 Aeterna Zentaris Company Details
11.1.2 Aeterna Zentaris Business Overview
11.1.3 Aeterna Zentaris Cancer Cachexia Introduction
11.1.4 Aeterna Zentaris Revenue in Cancer Cachexia Business (2016-2021)
11.1.5 Aeterna Zentaris Recent Development
11.2 Alder BioPharmaceuticals
11.2.1 Alder BioPharmaceuticals Company Details
11.2.2 Alder BioPharmaceuticals Business Overview
11.2.3 Alder BioPharmaceuticals Cancer Cachexia Introduction
11.2.4 Alder BioPharmaceuticals Revenue in Cancer Cachexia Business (2016-2021)
11.2.5 Alder BioPharmaceuticals Recent Development
11.3 Aphios
11.3.1 Aphios Company Details
11.3.2 Aphios Business Overview
11.3.3 Aphios Cancer Cachexia Introduction
11.3.4 Aphios Revenue in Cancer Cachexia Business (2016-2021)
11.3.5 Aphios Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Cancer Cachexia Introduction
11.4.4 Eli Lilly Revenue in Cancer Cachexia Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 GTx
11.5.1 GTx Company Details
11.5.2 GTx Business Overview
11.5.3 GTx Cancer Cachexia Introduction
11.5.4 GTx Revenue in Cancer Cachexia Business (2016-2021)
11.5.5 GTx Recent Development
11.6 Helsinn
11.6.1 Helsinn Company Details
11.6.2 Helsinn Business Overview
11.6.3 Helsinn Cancer Cachexia Introduction
11.6.4 Helsinn Revenue in Cancer Cachexia Business (2016-2021)
11.6.5 Helsinn Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Cancer Cachexia Introduction
11.7.4 Merck Revenue in Cancer Cachexia Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Cancer Cachexia Introduction
11.8.4 Novartis Revenue in Cancer Cachexia Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Cancer Cachexia Introduction
11.9.4 Bristol-Myers Squibb Revenue in Cancer Cachexia Business (2016-2021)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 XBiotech
11.10.1 XBiotech Company Details
11.10.2 XBiotech Business Overview
11.10.3 XBiotech Cancer Cachexia Introduction
11.10.4 XBiotech Revenue in Cancer Cachexia Business (2016-2021)
11.10.5 XBiotech Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cancer Cachexia Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Progestogens
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Combination Therapies
Table 5. Key Players of Others
Table 6. Global Cancer Cachexia Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cancer Cachexia Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cancer Cachexia Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cancer Cachexia Market Share by Regions (2016-2021)
Table 10. Global Cancer Cachexia Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cancer Cachexia Market Share by Regions (2022-2027)
Table 12. Cancer Cachexia Market Trends
Table 13. Cancer Cachexia Market Drivers
Table 14. Cancer Cachexia Market Challenges
Table 15. Cancer Cachexia Market Restraints
Table 16. Global Cancer Cachexia Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cancer Cachexia Market Share by Players (2016-2021)
Table 18. Global Top Cancer Cachexia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Cachexia as of 2020)
Table 19. Ranking of Global Top Cancer Cachexia Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cancer Cachexia Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cancer Cachexia Product Solution and Service
Table 23. Date of Enter into Cancer Cachexia Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Cachexia Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cancer Cachexia Revenue Market Share by Type (2016-2021)
Table 27. Global Cancer Cachexia Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cancer Cachexia Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cancer Cachexia Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cancer Cachexia Revenue Market Share by Application (2016-2021)
Table 31. Global Cancer Cachexia Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cancer Cachexia Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cancer Cachexia Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cancer Cachexia Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cancer Cachexia Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cancer Cachexia Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cancer Cachexia Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cancer Cachexia Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cancer Cachexia Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cancer Cachexia Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cancer Cachexia Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cancer Cachexia Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cancer Cachexia Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cancer Cachexia Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cancer Cachexia Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cancer Cachexia Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cancer Cachexia Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cancer Cachexia Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cancer Cachexia Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cancer Cachexia Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cancer Cachexia Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cancer Cachexia Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cancer Cachexia Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cancer Cachexia Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cancer Cachexia Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cancer Cachexia Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cancer Cachexia Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cancer Cachexia Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cancer Cachexia Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cancer Cachexia Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cancer Cachexia Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cancer Cachexia Market Size by Country (2022-2027) & (US$ Million)
Table 63. Aeterna Zentaris Company Details
Table 64. Aeterna Zentaris Business Overview
Table 65. Aeterna Zentaris Cancer Cachexia Product
Table 66. Aeterna Zentaris Revenue in Cancer Cachexia Business (2016-2021) & (US$ Million)
Table 67. Aeterna Zentaris Recent Development
Table 68. Alder BioPharmaceuticals Company Details
Table 69. Alder BioPharmaceuticals Business Overview
Table 70. Alder BioPharmaceuticals Cancer Cachexia Product
Table 71. Alder BioPharmaceuticals Revenue in Cancer Cachexia Business (2016-2021) & (US$ Million)
Table 72. Alder BioPharmaceuticals Recent Development
Table 73. Aphios Company Details
Table 74. Aphios Business Overview
Table 75. Aphios Cancer Cachexia Product
Table 76. Aphios Revenue in Cancer Cachexia Business (2016-2021) & (US$ Million)
Table 77. Aphios Recent Development
Table 78. Eli Lilly Company Details
Table 79. Eli Lilly Business Overview
Table 80. Eli Lilly Cancer Cachexia Product
Table 81. Eli Lilly Revenue in Cancer Cachexia Business (2016-2021) & (US$ Million)
Table 82. Eli Lilly Recent Development
Table 83. GTx Company Details
Table 84. GTx Business Overview
Table 85. GTx Cancer Cachexia Product
Table 86. GTx Revenue in Cancer Cachexia Business (2016-2021) & (US$ Million)
Table 87. GTx Recent Development
Table 88. Helsinn Company Details
Table 89. Helsinn Business Overview
Table 90. Helsinn Cancer Cachexia Product
Table 91. Helsinn Revenue in Cancer Cachexia Business (2016-2021) & (US$ Million)
Table 92. Helsinn Recent Development
Table 93. Merck Company Details
Table 94. Merck Business Overview
Table 95. Merck Cancer Cachexia Product
Table 96. Merck Revenue in Cancer Cachexia Business (2016-2021) & (US$ Million)
Table 97. Merck Recent Development
Table 98. Novartis Company Details
Table 99. Novartis Business Overview
Table 100. Novartis Revenue in Cancer Cachexia Business (2016-2021) & (US$ Million)
Table 101. Novartis Recent Development
Table 102. Bristol-Myers Squibb Company Details
Table 103. Bristol-Myers Squibb Business Overview
Table 104. Bristol-Myers Squibb Cancer Cachexia Product
Table 105. Bristol-Myers Squibb Revenue in Cancer Cachexia Business (2016-2021) & (US$ Million)
Table 106. Bristol-Myers Squibb Recent Development
Table 107. XBiotech Company Details
Table 108. XBiotech Business Overview
Table 109. XBiotech Cancer Cachexia Product
Table 110. XBiotech Revenue in Cancer Cachexia Business (2016-2021) & (US$ Million)
Table 111. XBiotech Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Cachexia Market Share by Type: 2020 VS 2027
Figure 2. Progestogens Features
Figure 3. Corticosteroids Features
Figure 4. Combination Therapies Features
Figure 5. Others Features
Figure 6. Global Cancer Cachexia Market Share by Application: 2020 VS 2027
Figure 7. Hospital Stores Case Studies
Figure 8. Retails Pharmacy Store Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Cancer Cachexia Report Years Considered
Figure 11. Global Cancer Cachexia Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cancer Cachexia Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cancer Cachexia Market Share by Regions: 2020 VS 2027
Figure 14. Global Cancer Cachexia Market Share by Regions (2022-2027)
Figure 15. Global Cancer Cachexia Market Share by Players in 2020
Figure 16. Global Top Cancer Cachexia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Cachexia as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cancer Cachexia Revenue in 2020
Figure 18. Global Cancer Cachexia Revenue Market Share by Type (2016-2021)
Figure 19. Global Cancer Cachexia Revenue Market Share by Type (2022-2027)
Figure 20. North America Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cancer Cachexia Market Share by Type (2016-2027)
Figure 22. North America Cancer Cachexia Market Share by Application (2016-2027)
Figure 23. North America Cancer Cachexia Market Share by Country (2016-2027)
Figure 24. United States Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cancer Cachexia Market Share by Type (2016-2027)
Figure 28. Europe Cancer Cachexia Market Share by Application (2016-2027)
Figure 29. Europe Cancer Cachexia Market Share by Country (2016-2027)
Figure 30. Germany Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cancer Cachexia Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cancer Cachexia Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cancer Cachexia Market Share by Region (2016-2027)
Figure 40. China Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cancer Cachexia Market Share by Type (2016-2027)
Figure 48. Latin America Cancer Cachexia Market Share by Application (2016-2027)
Figure 49. Latin America Cancer Cachexia Market Share by Country (2016-2027)
Figure 50. Mexico Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cancer Cachexia Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cancer Cachexia Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cancer Cachexia Market Share by Country (2016-2027)
Figure 56. Turkey Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cancer Cachexia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Aeterna Zentaris Revenue Growth Rate in Cancer Cachexia Business (2016-2021)
Figure 60. Alder BioPharmaceuticals Revenue Growth Rate in Cancer Cachexia Business (2016-2021)
Figure 61. Aphios Revenue Growth Rate in Cancer Cachexia Business (2016-2021)
Figure 62. Eli Lilly Revenue Growth Rate in Cancer Cachexia Business (2016-2021)
Figure 63. GTx Revenue Growth Rate in Cancer Cachexia Business (2016-2021)
Figure 64. Helsinn Revenue Growth Rate in Cancer Cachexia Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Cancer Cachexia Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Cancer Cachexia Business (2016-2021)
Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Cancer Cachexia Business (2016-2021)
Figure 68. XBiotech Revenue Growth Rate in Cancer Cachexia Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界のがん治療市場規模・現状・予測（2021年-2027年） Cancer therapy describes the treatment of cancer in a patient, often with surgery, chemotherapy and/or radiotherapy. Targeted therapies are also available for some cancer types. A cancer patient might receive many different types of therapy, including those aimed at relieving the symptoms of cancer,…- 世界の精密がん治療市場規模・現状・予測（2021年-2027年） Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy. Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormali…
- 世界の抗ホルモン療法市場規模・現状・予測（2021年-2027年） Antihormonal Cancer Therapy is a treatment with drugs, surgery, or radiation in order to block the production or action of a hormone. Antihormone therapy may be used in cancer treatment because certain hormones are able to stimulate the growth of some types of tumors. Market Analysis and Insights: G…
- 世界の子宮頸がん治療法・診断市場規模・現状・予測（2021年-2027年） Therapies and Diagnostics for Cervical Cancer refers to a series of methods and medical devices that can be used for the diagnosis and treatment of cervical cancer. The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually ac…
- 世界の前立腺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Prostate Cancer Therapeutics Market The global Prostate Cancer Therapeutics market size is projected to reach US$ 9677.3 million by 2026, from US$ 7420 million in 2019, at a CAGR of 3.8% during 2021-2026. With industry-standard accuracy in analysis and high data …